Clinical and biochemical markers of visceral adipose tissue activity: Body mass index, visceral adiposity index, leptin, adiponectin, and matrix metalloproteinase-3. Correlation with Gleason patterns 4 and 5 at prostate biopsy
Context: The correlation between aggressive prostate cancer and obesity mainly based on body mass index (BMI) and pathology after surgery remains controversial. Aims: The aim of the study was to correlate BMI, visceral adiposity index (VAI), and the plasmatic levels of leptin, adiponectin, and matri...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2018-01-01
|
Series: | Urology Annals |
Subjects: | |
Online Access: | http://www.urologyannals.com/article.asp?issn=0974-7796;year=2018;volume=10;issue=3;spage=280;epage=286;aulast=Serretta |
id |
doaj-5b1dc3369ae14e5eaa54cd3aa4673cd5 |
---|---|
record_format |
Article |
spelling |
doaj-5b1dc3369ae14e5eaa54cd3aa4673cd52020-11-25T02:28:17ZengWolters Kluwer Medknow PublicationsUrology Annals0974-77960974-78342018-01-0110328028610.4103/UA.UA_188_17Clinical and biochemical markers of visceral adipose tissue activity: Body mass index, visceral adiposity index, leptin, adiponectin, and matrix metalloproteinase-3. Correlation with Gleason patterns 4 and 5 at prostate biopsyVincenzo SerrettaAlberto AbrateSimone SiracusanoCristina Scalici GesolfoMarco VellaFabrizio Di MaidaAntonina CangemiGiuseppe CiceroElisabetta BarresiChiara SanfilippoContext: The correlation between aggressive prostate cancer and obesity mainly based on body mass index (BMI) and pathology after surgery remains controversial. Aims: The aim of the study was to correlate BMI, visceral adiposity index (VAI), and the plasmatic levels of leptin, adiponectin, and matrix metalloproteinase-3 (MMP-3), and biomarkers of adipose tissue function, with the detection of Gleason patterns 4 and 5 at biopsy. Subjects and Methods: Consecutive patients with prostate cancer at 12-core transrectal biopsy were enrolled. BMI, waist circumference (WC), blood samples to evaluate the plasmatic levels of triglycerides (TG) and high-density lipoproteins (HDL), adiponectin, leptin, and MMP-3 were obtained immediately before biopsy. The VAI was calculated according to the formula: WC/(39.68 + [1.88 × BMI]) × TG/1.03 × 1.31/HDL. Results: One hundred and forty-nine patients were entered. The median PSA, BMI, and VAI were 10.0 ng/ml, 27.6 kg/m2, and 4.6, respectively. Gleason patterns 4 or 5 were detected in 68 (45.6%) patients; in 15 (41.7%), 31 (44.9%), and 22 (50.0%) among normal weight, overweight, and obese patients, respectively (P = 0.55). The statistical analysis did not show any significant correlation between BMI, VAI, the plasmatic levels of leptin, adiponectin, MMP-3, and the detection of Gleason patterns 4 and 5 at biopsy. A statistically significant association emerged with older age (P = 0.017) and higher PSA values (P = 0.02). Conclusion: We did not find any association between BMI, VAI, the plasmatic levels of adiponectin, leptin, and MMP-3 and the detection of Gleason patterns 4 and 5 at prostate biopsy.http://www.urologyannals.com/article.asp?issn=0974-7796;year=2018;volume=10;issue=3;spage=280;epage=286;aulast=SerrettaAdiponectinbody mass indexGleason patternleptinmatrix metalloproteinase-3obesityprostate cancervisceral adiposity index |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Vincenzo Serretta Alberto Abrate Simone Siracusano Cristina Scalici Gesolfo Marco Vella Fabrizio Di Maida Antonina Cangemi Giuseppe Cicero Elisabetta Barresi Chiara Sanfilippo |
spellingShingle |
Vincenzo Serretta Alberto Abrate Simone Siracusano Cristina Scalici Gesolfo Marco Vella Fabrizio Di Maida Antonina Cangemi Giuseppe Cicero Elisabetta Barresi Chiara Sanfilippo Clinical and biochemical markers of visceral adipose tissue activity: Body mass index, visceral adiposity index, leptin, adiponectin, and matrix metalloproteinase-3. Correlation with Gleason patterns 4 and 5 at prostate biopsy Urology Annals Adiponectin body mass index Gleason pattern leptin matrix metalloproteinase-3 obesity prostate cancer visceral adiposity index |
author_facet |
Vincenzo Serretta Alberto Abrate Simone Siracusano Cristina Scalici Gesolfo Marco Vella Fabrizio Di Maida Antonina Cangemi Giuseppe Cicero Elisabetta Barresi Chiara Sanfilippo |
author_sort |
Vincenzo Serretta |
title |
Clinical and biochemical markers of visceral adipose tissue activity: Body mass index, visceral adiposity index, leptin, adiponectin, and matrix metalloproteinase-3. Correlation with Gleason patterns 4 and 5 at prostate biopsy |
title_short |
Clinical and biochemical markers of visceral adipose tissue activity: Body mass index, visceral adiposity index, leptin, adiponectin, and matrix metalloproteinase-3. Correlation with Gleason patterns 4 and 5 at prostate biopsy |
title_full |
Clinical and biochemical markers of visceral adipose tissue activity: Body mass index, visceral adiposity index, leptin, adiponectin, and matrix metalloproteinase-3. Correlation with Gleason patterns 4 and 5 at prostate biopsy |
title_fullStr |
Clinical and biochemical markers of visceral adipose tissue activity: Body mass index, visceral adiposity index, leptin, adiponectin, and matrix metalloproteinase-3. Correlation with Gleason patterns 4 and 5 at prostate biopsy |
title_full_unstemmed |
Clinical and biochemical markers of visceral adipose tissue activity: Body mass index, visceral adiposity index, leptin, adiponectin, and matrix metalloproteinase-3. Correlation with Gleason patterns 4 and 5 at prostate biopsy |
title_sort |
clinical and biochemical markers of visceral adipose tissue activity: body mass index, visceral adiposity index, leptin, adiponectin, and matrix metalloproteinase-3. correlation with gleason patterns 4 and 5 at prostate biopsy |
publisher |
Wolters Kluwer Medknow Publications |
series |
Urology Annals |
issn |
0974-7796 0974-7834 |
publishDate |
2018-01-01 |
description |
Context: The correlation between aggressive prostate cancer and obesity mainly based on body mass index (BMI) and pathology after surgery remains controversial.
Aims: The aim of the study was to correlate BMI, visceral adiposity index (VAI), and the plasmatic levels of leptin, adiponectin, and matrix metalloproteinase-3 (MMP-3), and biomarkers of adipose tissue function, with the detection of Gleason patterns 4 and 5 at biopsy.
Subjects and Methods: Consecutive patients with prostate cancer at 12-core transrectal biopsy were enrolled. BMI, waist circumference (WC), blood samples to evaluate the plasmatic levels of triglycerides (TG) and high-density lipoproteins (HDL), adiponectin, leptin, and MMP-3 were obtained immediately before biopsy. The VAI was calculated according to the formula: WC/(39.68 + [1.88 × BMI]) × TG/1.03 × 1.31/HDL.
Results: One hundred and forty-nine patients were entered. The median PSA, BMI, and VAI were 10.0 ng/ml, 27.6 kg/m2, and 4.6, respectively. Gleason patterns 4 or 5 were detected in 68 (45.6%) patients; in 15 (41.7%), 31 (44.9%), and 22 (50.0%) among normal weight, overweight, and obese patients, respectively (P = 0.55). The statistical analysis did not show any significant correlation between BMI, VAI, the plasmatic levels of leptin, adiponectin, MMP-3, and the detection of Gleason patterns 4 and 5 at biopsy. A statistically significant association emerged with older age (P = 0.017) and higher PSA values (P = 0.02).
Conclusion: We did not find any association between BMI, VAI, the plasmatic levels of adiponectin, leptin, and MMP-3 and the detection of Gleason patterns 4 and 5 at prostate biopsy. |
topic |
Adiponectin body mass index Gleason pattern leptin matrix metalloproteinase-3 obesity prostate cancer visceral adiposity index |
url |
http://www.urologyannals.com/article.asp?issn=0974-7796;year=2018;volume=10;issue=3;spage=280;epage=286;aulast=Serretta |
work_keys_str_mv |
AT vincenzoserretta clinicalandbiochemicalmarkersofvisceraladiposetissueactivitybodymassindexvisceraladiposityindexleptinadiponectinandmatrixmetalloproteinase3correlationwithgleasonpatterns4and5atprostatebiopsy AT albertoabrate clinicalandbiochemicalmarkersofvisceraladiposetissueactivitybodymassindexvisceraladiposityindexleptinadiponectinandmatrixmetalloproteinase3correlationwithgleasonpatterns4and5atprostatebiopsy AT simonesiracusano clinicalandbiochemicalmarkersofvisceraladiposetissueactivitybodymassindexvisceraladiposityindexleptinadiponectinandmatrixmetalloproteinase3correlationwithgleasonpatterns4and5atprostatebiopsy AT cristinascalicigesolfo clinicalandbiochemicalmarkersofvisceraladiposetissueactivitybodymassindexvisceraladiposityindexleptinadiponectinandmatrixmetalloproteinase3correlationwithgleasonpatterns4and5atprostatebiopsy AT marcovella clinicalandbiochemicalmarkersofvisceraladiposetissueactivitybodymassindexvisceraladiposityindexleptinadiponectinandmatrixmetalloproteinase3correlationwithgleasonpatterns4and5atprostatebiopsy AT fabriziodimaida clinicalandbiochemicalmarkersofvisceraladiposetissueactivitybodymassindexvisceraladiposityindexleptinadiponectinandmatrixmetalloproteinase3correlationwithgleasonpatterns4and5atprostatebiopsy AT antoninacangemi clinicalandbiochemicalmarkersofvisceraladiposetissueactivitybodymassindexvisceraladiposityindexleptinadiponectinandmatrixmetalloproteinase3correlationwithgleasonpatterns4and5atprostatebiopsy AT giuseppecicero clinicalandbiochemicalmarkersofvisceraladiposetissueactivitybodymassindexvisceraladiposityindexleptinadiponectinandmatrixmetalloproteinase3correlationwithgleasonpatterns4and5atprostatebiopsy AT elisabettabarresi clinicalandbiochemicalmarkersofvisceraladiposetissueactivitybodymassindexvisceraladiposityindexleptinadiponectinandmatrixmetalloproteinase3correlationwithgleasonpatterns4and5atprostatebiopsy AT chiarasanfilippo clinicalandbiochemicalmarkersofvisceraladiposetissueactivitybodymassindexvisceraladiposityindexleptinadiponectinandmatrixmetalloproteinase3correlationwithgleasonpatterns4and5atprostatebiopsy |
_version_ |
1724839321867911168 |